Tue. 16 Apr 2024, 9:24am ET
Benzinga
M&A, News
- Acquisition capitalizes on TruHC's strategically built German cannabis platform, including:
- EU-GMP processing and production license
- GDP wholesale license for import / export
- EU-GMP certified customizable modules with flexibility to incorporate various production / packaging processes and which enable license extension for future in country cultivation and supply to cannabis dispensaries
- Narcotics license with EU-GMP certified storage
- EU-GMP certified laboratory for instant cannabis analysis
- Transaction combines Flora's extensive global CPG and pharmaceutical distribution network with TruHC's deep global cannabis expertise, including an executive team with extensive experience building successful medical and recreational cannabis companies across Germany, Canada, and the United States.
- Germany poised to become world's largest federally legal cannabis market with expected market potential of over $10 billion with federal legalization and the critical elimination of banking, financial, capital markets, and tax constraints faced by U.S. operators.